new and special drug
Praluent (Alirocumab) | ASCVD | HongKong DengYue Medicine
Repatha (Evolocumab) | ASCVD | HongKong DengYue Medicine
Nemluvio (Nemolizumab-ilto) – Prurigo Nodularis | HongKong DengYue Medicine
Livdelzi (Seladelpar) | Primary Biliary Cholangitis | DengYue Med
Yorvipath (Palopegteriparatide) | Hypoparathyroidism | DengYue Medicine
Voranigo (vorasidenib) – IDH1/IDH2-Mutant Grade 2 Gliomas
Sofdra (Sofpironium) | Primary Axillary Hyperhidrosis | DengYue
Ohtuvayre (Ensifentrine) – Chronic Obstructive Pulmonary Disease
Iqirvo (Elafibranor) | Primary Biliary Cholangitis | DengYue Medicine
Xolremdi (Mavorixafor) – WHIM | HongKong DengYue Medicine
Ojemda (Tovorafenib) – Pediatric Low-Grade Glioma | HongKong DengYue Medicine
Anktiva (Nogapendekin alfa inbakicept-pmln) – BCG-unresponsive NMIBC with CIS
Zevtera (Ceftobiprole medocaril sodium) – SAB,ABSSSI,CABP
Winrevair (Sotatercept-csrk) – Pulmonary Arterial Hypertension | HongKong DengYue Medicine
Tryvio (Aprocitentan) – Hypertension | HongKong DengYue Medicine
Resmetirom | Nonalcoholic Steatohepatitis | HongKong DengYue Med
